Five-year safety and performance results from the Argus II Retinal Prosthesis System clinical trial

PURPOSE: The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA) was developed to restore some vision to patients blind from retinitis pigmentosa (RP) or outer retinal degeneration. A clinical trial was initiated in 2006 to study the long-term safety and efficacy...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Ophthalmology
Main Authors: da Cruz, Lyndon, Dorn, Jessy D., Humayun, Mark S., Dagnelie, Gislin, Handa, James, Barale, Pierre-Olivier, Sahel, José-Alain, Stanga, Paulo E., Hafezi, Farhad, Safran, Avinoam B., Salzmann, Joel, Santos, Arturo, Birch, David, Spencer, Rand, Cideciyan, Artur V., de Juan, Eugene, Duncan, Jacque L., Eliott, Dean, Fawzi, Amani, Olmos de Koo, Lisa C., Ho, Allen C., Brown, Gary, Haller, Julia, Regillo, Carl, Del Priore, Lucian V., Arditi, Aries, Greenberg, Robert J.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2016
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035591/
https://ncbi.nlm.nih.gov/pubmed/27453256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.06.049
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים